With an income increase of 181.14% in the fourth quarter 2025, year on year to cumulative value of $8,296 million, and with 254 employees, Gsk Plc's income per employee grew on trailing twelve month basis to $ 32,662,867. The income per employee at Gsk Plc' was above the company average.
The Healthcare sector has seen employees in only one company achieving higher income per employee than the Gsk Plc. While Gsk Plc's total ranking has deteriorated compared to the previous quarter from 0 to 24.

What is Income per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Net Income per Employee▼

None ▼

Net Income per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GSK Net Income per Employee	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Net Income Change	181.14 %	-	-	-	-81.11 %
Net Income per Employee (TTM) $	32,662,867	11,618,110	11,618,110	11,618,110	11,618,110
GSK's Total Ranking	# 24	# 0	#	#	#
Seq. Net Income Change	-	-	-	-	-

GSK Company Profile >> Back to GSK Efficiency Comparisons >> Compare GSK Net Income per Employee to its Competitors

GSK Net Income per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 2
Healthcare Sector	# 2
Overall Market	# 24

Net Income per Employee Statistics
High	Average	Low
$ 61,500,000	$ 25,679,978	$ 11,618,110
(Dec 31 2022)		(Dec 31 2024)

News about Gsk Plc Income per employee

GSK Investors Alert Navigating Class Action Lawsuits Amidst Shares Performance

In recent news concerning GlaxoSmithKline plc (GSK), Bronstein, Gewirtz and Grossman LLC has announced a new opportunity for investors who have suffered substantial losses in their GSK investments. The law firm is inviting affected shareholders to participate in a potential class action lawsuit, in response to regulatory and market pressures that have impacted the company’s stock performance.While the announcement of a class action lawsuit might raise concerns among investors, it s important to contextualize GSK s overall performance in the market. As of this month, GSK shares have experienced a slight downturn, with a performance rate of -2.67% compared to their peers and the broader market. Despite this recent dip, GSK’s year-to-date performance has shown resilience, as the company’s shares have outperformed the market overall.

Companies with similar Income per Employee for 12 month ending Dec 31 2025, within Healthcare Sector	Income per Employee	Income 12 month ending Dec 31 2025	Number of Employees Dec 31 2025
Enlivex Therapeutics Ltd	36,339,058.82	$ 1,235.528 Million	34
Gsk Plc	24,759,842.52	$ 6,289.000 Million	254
Galera Therapeutics Inc	21,174,666.67	$ 63.524 Million	3

Date modified: 2026-09-09T12:36:18+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.